Effect of Stevioside (Stevia rebaudiana) on Entamoeba histolytica Trophozoites

Author:

Ortega-Carballo Karla1ORCID,Gil-Becerril Karla1ORCID,Acosta-Virgen Karla1,Casas-Grajales Sael2,Muriel Pablo2ORCID,Tsutsumi Víctor1

Affiliation:

1. Department of Infectomics and Molecular Pathogenesis, CINVESTAV-IPN, Mexico City 07360, Mexico

2. Laboratory of Experimental Hepatology, Department of Pharmacology, CINVESTAV-IPN, Mexico City 07360, Mexico

Abstract

Human amoebiasis still represents a major health problem worldwide. Metronidazole has been used as the most common drug to treat the disease; however, it is also known that the drug causes undesirable side effects. This has led to the search for new pharmacological alternatives which include phytochemical compounds with antiamoebic effects. We analyzed the amoebicidal activity of stevioside (STV), a diterpene glycoside present in Stevia rebaudiana, on trophozoites of E. histolytica. Different concentrations of STV were tested, and an inhibitory concentration of 50% of cell viability (IC50) was determined with an exposition of 9.53 mM for 24 h. Trophozoites exposed to STV showed morphological changes evidenced by the decrease in the basic structures related to the movement and adherence to the substrate, as well as ultrastructural features characterized by a loss of regularity on the cell membrane, an increase in cytoplasmic granularity, and an increase in apparent autophagic vacuoles. Also, the decrease in cysteine protease expression and the proteolytic activity of trophozoites to degrade the cell monolayer were analyzed. A histological analysis of hamster livers inoculated with trophozoites and treated with STV showed changes related to the granulomatous reaction of the liver parenchymal tissue. Our results constitute the first report related to the possible use of STV as a therapeutic alternative in amoebiasis.

Funder

CONAHCYT

Publisher

MDPI AG

Reference33 articles.

1. Entamoeba histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development;Kantor;Can. J. Gastroenterol. Hepatol.,2018

2. Chacín-Bonilla Leonor (2023, December 04). Current pharmacotherapy of amoebiasis, advances in new drugs and design of a vaccine. Available online: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0535-51332012000300008&lng=es.

3. Amebiasis;Haque;New Engl. J. Med.,2003

4. Amoebic dysentery;Marie;BMJ Clin. Evid.,2013

5. Martínez-Castillo, M., Pacheco-Yepez, J., Flores-Huerta, N., Guzmán-Téllez, P., Jarillo-Luna, R.A., Cárdenas-Jaramillo, L.M., Campos-Rodríguez, R., and Shibayama, M. (2018). Flavonoids as a Natural Treatment Against Entamoeba histolytica. Front. Cell. Infect. Microbiol., 8.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3